Management of hepatitis B: A longitudinal national survey - Impact of the Canadian hepatitis B consensus guidelines

Canadian Journal of Gastroenterology

Volumn 24, Issue 9, 2010, Pages 537-542

  Marotta, Paul ^a   Lucas, Kurt ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b Extension Marketing Inc   (Canada)

Author keywords

Guidelines; Longitudinal; Management; Reimbursement

Indexed keywords

ADEFOVIR; ENTECAVIR; LAMIVUDINE; PEGINTERFERON ALPHA2A; TELBIVUDINE; TENOFOVIR;

ARTICLE; CANADA; CLINICAL PRACTICE; HEPATITIS B; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 77956904070     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/931326     Document Type: Article

References (2)

1. Block TM, Mehta AS, Fimmel CJ, et al. Molecular viral oncology and hepatocellular carcinoma. Oncogene 2003;22:5093-107.
2. Sherman M, Shafran S, Burak K, et al. Management of chronic hepatitis B: Consensus guidelines. Can J Gastroenterol 2007;21(Suppl C):1-20.